首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nucleic acid therapeutics

缩写:NUCLEIC ACID THER

ISSN:2159-3337

e-ISSN:2159-3345

IF/分区:4.5/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引621
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sepideh Kaviani,Hassan H Fakih,Jathavan Asohan et al. Sepideh Kaviani et al.
Antisense oligonucleotides (ASOs) can predictably alter RNA processing and control protein expression; however, challenges in the delivery of these therapeutics to specific tissues, poor cellular uptake, and endosomal escape have impeded pr...
Haiyan Zhou,Virginia Arechavala-Gomeza,Alejandro Garanto Haiyan Zhou
Preclinical evaluation of nucleic acid therapeutics (NATs) in relevant experimental model systems is essential for NAT drug development. As part of COST Action "DARTER" (Delivery of Antisense RNA ThERapeutics), a network of researchers in t...
Khalequz Zaman,Adi Breitman,Isa Malik et al. Khalequz Zaman et al.
The leading cause of death in adults in the United States is cardiovascular disease, with mortality and morbidity mainly attributed to thromboembolism. Heparin is the most common therapy used for treating venous and arterial thrombosis. Hep...
Leon M Larcher,Ianthe L Pitout,Niall P Keegan et al. Leon M Larcher et al.
Nucleic acids drugs have been proven in the clinic as a powerful modality to treat inherited and acquired diseases. However, key challenges including drug stability, renal clearance, cellular uptake, and movement across biological barriers ...
Lijiang Shen,Andrea Wong,Satoru Oneda et al. Lijiang Shen et al.
2'-O-Methoxyethyl antisense oligonucleotide (2'-MOE ASO)-induced severe thrombocytopenia (TCP) [platelet (PLT) count 5 mg/kg/week). The potential mechanisms for TCP were studied using the Mauritian-sourced cynomolgus monkeys, which were sho...
Judith van Deutekom,Chantal Beekman,Suzanne Bijl et al. Judith van Deutekom et al.
In the last two decades, antisense oligonucleotides (AONs) that induce corrective exon skipping have matured as promising therapies aimed at tackling the dystrophin deficiency that underlies the severe and progressive muscle fiber degenerat...
Tobias Wimmer,Hannah Sawinski,Anne M Urban et al. Tobias Wimmer et al.
Stargardt disease (STGD) leads to blindness in children and young adults. So far, no curative therapy is available and gene augmentation therapies have not yet advanced to the clinics, in part, due to the limited packaging capacity of adeno...
Sean D McCarthy,Christopher B Rohde,Matt Angel et al. Sean D McCarthy et al.
Acute respiratory distress syndrome (ARDS), a rapid onset inflammatory lung disease with no effective specific therapy, typically has pathogenic etiology termed pneumonia. In previous studies nuclear factor-κB (NF-κB) inhibitor α super-r...
Daniel Paul DeCollibus,Justin Searcy,Anna Tivesten et al. Daniel Paul DeCollibus et al.
A primary function of the parenteral drug product manufacturing process is to ensure sterility of the final product. The two most common methods for sterilizing parenteral drug products are terminal sterilization (TS), whereby the drug prod...
Adam J Pollak,Luyi Zhao,Stanley T Crooke Adam J Pollak
While rare, some gapmer phosphorothioate (PS) antisense oligonucleotides (ASOs) can induce a noncanonical TLR9-dependent innate immune response. In this study, we performed systematic analyses of the roles of PS ASO backbone chemistry, 2' m...